Radio and PodcastRadio and PodcastLive Radio & Podcasts
Raising $200M & Building AI for Drug Discovery BenchSci Co-founder and CEO, Liran Belenzon artwork
Business

Raising $200M & Building AI for Drug Discovery BenchSci Co-founder and CEO, Liran Belenzon

Innovation and Leadership with Jess Larsen by Graystoke Networks

May 28, 202643:58Business

Most people don’t realize how broken drug discovery really is. According to Liran Belenzon, companies can spend seven years and hundreds of millions of dollars on a drug candidate—only to see it fail in human trials. In...

About This Episode

Raising $200M & Building AI for Drug Discovery BenchSci Co-founder and CEO, Liran Belenzon is an episode from Innovation and Leadership with Jess Larsen by Graystoke Networks. Most people don’t realize how broken drug discovery really is. A...

Podcast

This episode belongs to Innovation and Leadership with Jess Larsen.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published May 28, 2026, 43:58 long, audio available.